Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Temozolomide and unusual indications: review of literature.

Tatar Z, Thivat E, Planchat E, Gimbergues P, Gadea E, Abrial C, Durando X.

Cancer Treat Rev. 2013 Apr;39(2):125-35. doi: 10.1016/j.ctrv.2012.06.002. Epub 2012 Jul 19. Review.

PMID:
22818211
2.

Temozolomide for Treating Malignant Melanoma.

Li RH, Hou XY, Yang CS, Liu WL, Tang JQ, Liu YQ, Jiang G.

J Coll Physicians Surg Pak. 2015 Sep;25(9):680-8. doi: 09.2015/JCPSP.680688. Review.

PMID:
26374366
3.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

5.

Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.

Annamalai AK, Dean AF, Kandasamy N, Kovacs K, Burton H, Halsall DJ, Shaw AS, Antoun NM, Cheow HK, Kirollos RW, Pickard JD, Simpson HL, Jefferies SJ, Burnet NG, Gurnell M.

Pituitary. 2012 Sep;15(3):276-87. doi: 10.1007/s11102-011-0363-7. Review.

PMID:
22076588
6.

Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A.

Anticancer Res. 2003 Nov-Dec;23(6D):5159-64.

PMID:
14981983
7.

[Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].

Conill C, Fernández-Ibiza J, Malvehy J, Puig S, Sánchez M, Castel T.

Med Clin (Barc). 2004 Mar 27;122(11):413-5. Spanish.

PMID:
15066248
8.

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Tentori L, Leonetti C, Scarsella M, D'Amati G, Vergati M, Portarena I, Xu W, Kalish V, Zupi G, Zhang J, Graziani G.

Clin Cancer Res. 2003 Nov 1;9(14):5370-9.

9.

Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.

Kouvaris JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous XN, Vlahos LJ.

Onkologie. 2007 Jul;30(7):361-6. Epub 2007 Jun 27.

PMID:
17596744
10.

Treatment of brain metastases of malignant melanoma with temozolomide.

Biasco G, Pantaleo MA, Casadei S.

N Engl J Med. 2001 Aug 23;345(8):621-2. No abstract available.

11.

The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of action.

Bei R, Marzocchella L, Turriziani M.

Recent Pat Anticancer Drug Discov. 2010 Nov;5(3):172-87. Review.

PMID:
20594183
12.

Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.

Carlson BL, Grogan PT, Mladek AC, Schroeder MA, Kitange GJ, Decker PA, Giannini C, Wu W, Ballman KA, James CD, Sarkaria JN.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):212-9. doi: 10.1016/j.ijrobp.2009.04.026.

13.

The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.

Sher DJ, Henson JW, Avutu B, Hochberg FH, Batchelor TT, Martuza RL, Barker FG 2nd, Loeffler JS, Chakravarti A.

J Neurooncol. 2008 May;88(1):43-50. doi: 10.1007/s11060-008-9530-8. Epub 2008 Jan 30.

14.

The safety of temozolomide in the treatment of malignancies.

Trinh VA, Patel SP, Hwu WJ.

Expert Opin Drug Saf. 2009 Jul;8(4):493-9. doi: 10.1517/14740330902918281 . Review.

PMID:
19435405
15.

How effective is temozolomide for treating pituitary tumours and when should it be used?

Halevy C, Whitelaw BC.

Pituitary. 2017 Apr;20(2):261-266. doi: 10.1007/s11102-016-0745-y. Review.

PMID:
27581836
16.

Temozolomide: a milestone in the pharmacotherapy of brain tumors.

Weller M, Steinbach JP, Wick W.

Future Oncol. 2005 Dec;1(6):747-54. Review.

PMID:
16556052
17.

Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.

Giorgio CG, Giuffrida D, Pappalardo A, Russo A, Santini D, Salice P, Blanco G, Castorina S, Failla G, Bordonaro R.

Lung Cancer. 2005 Nov;50(2):247-54. Epub 2005 Jul 20.

PMID:
16039010
18.

Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.

Kocher M, Frommolt P, Borberg SK, Rühl U, Steingräber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H, Müller RP.

Strahlenther Onkol. 2008 Nov;184(11):572-9. doi: 10.1007/s00066-008-1897-0. Epub 2008 Nov 19.

PMID:
19016015
19.
20.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389

Supplemental Content

Support Center